The Global Colon Cancer Association (GCCA) advocates for equitable access to quality colorectal cancer screenings, testing, treatments, and care, because where you live should not determine whether you can prevent or survive colorectal cancer. As both a membership-based umbrella organization and a patient advocacy organization, GCCA works toward this goal by amplifying and supporting the efforts of our member organizations, by developing adaptable advocacy and educational materials for our members, and by conducting our own advocacy, education, and initiatives that ensure patients are at the heart of all policy discussions.
The Global Colon Cancer Association was formed in 2011 by Jola Gore-Booth, co-founder and former CEO of EuropaColon, and Andrew Spiegel, co-founder and former CEO of the Colorectal Cancer Alliance.
GCCA was founded with the goal of creating a global community in which people around the world can join together and battle this disease with one united voice. Over the last decade, GCCA has grown to become a patient advocacy organization and an umbrella organization for patient advocacy groups, healthcare and research institutions, professional societies, and industry partners worldwide who are united against colorectal cancer.
Collaboration is vital to the Global Colon Cancer Association’s mission. GCCA is proud to participate in multi-stakeholder partnerships working towards our shared goal of equitable access to quality colorectal cancer screenings, testing, treatments, and care. GCCA is a member of several organizations and coalitions, and our leadership team members serve on various boards and committees.